<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ajmb
   </journal-id>
   <journal-title-group>
    <journal-title>
     American Journal of Molecular Biology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2161-6620
   </issn>
   <issn publication-format="print">
    2161-6663
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ajmb.2024.144018
   </article-id>
   <article-id pub-id-type="publisher-id">
    ajmb-136516
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Biomedical 
     </subject>
     <subject>
       Life Sciences
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Prevalence and Antibiotic Resistance of Urinary Tract Pathogens, with Molecular Identification of Klebsiella pneumoniae, Klebsiella oxytoca, and Acinetobacter spp., Using Multiplex Real-Time PCR
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Hawa
      </surname>
      <given-names>
       Tarnagda
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Djénéba
      </surname>
      <given-names>
       Ouermi
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Tani
      </surname>
      <given-names>
       Sagna
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Wendyam Marie Christelle
      </surname>
      <given-names>
       Nadembega
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Abdoul Karim
      </surname>
      <given-names>
       Ouattara
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Lassina
      </surname>
      <given-names>
       Traoré
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Rogomenoma Alice
      </surname>
      <given-names>
       Ouedraogo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref> 
     <xref ref-type="aff" rid="aff6"> 
      <sup>6</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Prosper
      </surname>
      <given-names>
       Bado
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Bapio Valérie Elvira Jean Télesphore
      </surname>
      <given-names>
       Bazie
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Nicole
      </surname>
      <given-names>
       Bouda/Zongo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff7"> 
      <sup>7</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Luc
      </surname>
      <given-names>
       Zongo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff7"> 
      <sup>7</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Albert Théophane
      </surname>
      <given-names>
       Yonli
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Théodora Mahoukèdè
      </surname>
      <given-names>
       Zohoncon
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref> 
     <xref ref-type="aff" rid="aff7"> 
      <sup>7</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Florencia Wendkuuni
      </surname>
      <given-names>
       Djigma
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Jacques
      </surname>
      <given-names>
       Simpore
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref> 
     <xref ref-type="aff" rid="aff7"> 
      <sup>7</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aCentre de Recherche Biomoléculaire Pietro Annigoni (CERBA), Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aUniversity Saint Thomas d’Aquin (USTA), Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff3">
    <addr-line>
     aLaboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff4">
    <addr-line>
     aInstitute for Research in Applied Sciences (IRSS/CNRST), Ouaga, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff5">
    <addr-line>
     aUniversité Norbert Zongo/Centre Universitaire de Manga, Avenue Maurice Yameogo, Koudougou, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff6">
    <addr-line>
     aUniversité Nazi BONI, Bobo-Dioulasso, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff7">
    <addr-line>
     aHôpital Saint Camille de Ouagadougou (HOSCO), Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     27
    </day> 
    <month>
     08
    </month>
    <year>
     2024
    </year>
   </pub-date> 
   <volume>
    14
   </volume> 
   <issue>
    04
   </issue>
   <fpage>
    245
   </fpage>
   <lpage>
    260
   </lpage>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    Urinary tract infections (UTIs) caused by uropathogens are a significant public health problem, and their treatment primarily relies on antibiotic therapy. However, the increasing global development of antibiotic resistance necessitates updating diagnostic techniques to ensure higher sensitivity and specificity, especially with advancements in science and medicine. This study aimed to evaluate the prevalence of UTIs and antibiotic resistance profiles through urine culture, as well as to identify Klebsiella pneumoniae, Klebsiella oxytoca, and Acinetobacter spp. in urine samples using a molecular approach with multiplex real-time PCR. From May 3 to July 25, 2023, at the Pietro Annigoni Biomolecular Research Center (CERBA) and Saint Camille Hospital of Ouagadougou (HOSCO), 209 urine samples collected from patients with suspected UTIs were analyzed using both urine culture and multiplex real-time PCR. Among the 209 patients, 52.15% were male and 47.85% female, with an average age of 46.87 ± 21.33 years. Urine cultures revealed an overall UTI prevalence of 23.44%, with a prevalence of 8.13% in men versus 15.31% in women (P = 0.023). The bacterial prevalence rates were as follows: Escherichia coli (12.92%), Klebsiella spp. (7.18%), Enterobacter cloacae (1.44%), Staphylococcus aureus (0.96%), and other bacteria. Klebsiella spp. demonstrated 100% resistance to Amoxicillin and Amoxicillin/Clavulanic Acid, while Escherichia coli showed 96.2% and 65.4% resistance to Amoxicillin and Amoxicillin/Clavulanic Acid, respectively. PCR analysis of the target bacteria revealed mono-infection prevalence rates of Klebsiella pneumoniae (10.39%), Klebsiella oxytoca (7.79%), and Acinetobacter spp. (7.79%), along with a co-infection prevalence rate of Klebsiella pneumoniae/Acinetobacter spp. (1.30%). This study demonstrated that PCR, with its high sensitivity and specificity, could effectively distinguish Klebsiella pneumoniae from Klebsiella oxytoca and detect Acinetobacter spp. in less than 24 hours—something urine culture alone could not achieve. The relative ease of automating urine PCR testing, combined with its diagnostic accuracy and rapid turnaround time, makes it a valuable addition to modern medical practice for the laboratory diagnosis of UTIs.
   </abstract>
   <kwd-group> 
    <kwd>
     Urinary Tract Infections
    </kwd> 
    <kwd>
      Klebsiella pneumoniae
    </kwd> 
    <kwd>
      Klebsiella oxytoca
    </kwd> 
    <kwd>
      Acinetobacter spp.
    </kwd> 
    <kwd>
      Urine Culture
    </kwd> 
    <kwd>
      Real-Time PCR
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Among the most common bacterial infections are Urinary Tract Infections (UTIs), which pose a major public health challenge, affecting individuals of all ages <xref ref-type="bibr" rid="scirp.136516-1">
     [1]
    </xref>. Uropathogens such as Klebsiella spp., Escherichia coli, Acinetobacter spp., Staphylococcus spp., and other pathogenic bacteria are frequent causes of nosocomial infections, including UTIs, which contribute significantly to mortality in clinical settings <xref ref-type="bibr" rid="scirp.136516-2">
     [2]
    </xref>-<xref ref-type="bibr" rid="scirp.136516-6">
     [6]
    </xref>. UTIs are the leading cause of morbidity in the general population and are the second most common infectious disease after respiratory infections <xref ref-type="bibr" rid="scirp.136516-7">
     [7]
    </xref>. Each year, approximately 150 million people worldwide are diagnosed with UTIs, resulting in a global economic burden exceeding US$6 billion <xref ref-type="bibr" rid="scirp.136516-8">
     [8]
    </xref>. Historically, UTIs have been recognized for millennia. As early as the 16th century BC, they were described in the Ebers Papyrus, one of the oldest surviving medical texts. The Egyptians attributed UTIs to heat in the bladder and treated them with herbal decoctions, bloodletting, and rest (Bent et al., 2002) <xref ref-type="bibr" rid="scirp.136516-9">
     [9]
    </xref>. Effective treatments for UTIs only emerged in the 1930s with the discovery of antibiotics.</p>
   <p>Despite advances in diagnostics and the widespread use of antibiotic therapy, antimicrobial resistance (AMR) in uropathogens remains a significant concern <xref ref-type="bibr" rid="scirp.136516-10">
     [10]
    </xref>. UTIs, caused by the colonization of the urinary tract by infectious agents, lead to an inflammatory response in the urothelium. Among the pathogens involved, bacteria of the Klebsiella and Acinetobacter genera play a predominant role <xref ref-type="bibr" rid="scirp.136516-11">
     [11]
    </xref>.</p>
   <p>The diagnosis of UTIs is based on clinical symptoms, as well as the detection and identification of microorganisms in urine <xref ref-type="bibr" rid="scirp.136516-9">
     [9]
    </xref>. UTIs are prevalent in both community and hospital settings and affect people across all demographics <xref ref-type="bibr" rid="scirp.136516-12">
     [12]
    </xref>. However, women are four times more likely than men to develop UTIs due to anatomical differences <xref ref-type="bibr" rid="scirp.136516-13">
     [13]
    </xref>.</p>
   <p>Currently, particularly in low-income countries, the standard method for diagnosing UTIs remains the Cytobacteriological Examination of Urine (CEBU) through urine culture <xref ref-type="bibr" rid="scirp.136516-14">
     [14]
    </xref>. Urine culture provides valuable information regarding the presence or absence of a uropathogen, facilitates identification of the causative organism, and in some cases, determines antibiotic susceptibility or resistance. However, the main limitation of this method is the time required to obtain results, which typically takes 2 to 3 days <xref ref-type="bibr" rid="scirp.136516-14">
     [14]
    </xref>. To alleviate patient symptoms, empirical antibiotic therapy is often initiated while awaiting these results. This practice, however, can contribute to the overuse of antibiotics.</p>
   <p>The development of a rapid diagnostic system based on molecular biology, such as automated urine analysis, could provide same-day results, detecting the presence or absence of significant bacteriuria, identifying the pathogen, and determining genetic resistance. Such a system could also reduce the need for urine culture in many negative cases, preventing unnecessary antibiotic prescriptions for patients who do not require them.</p>
   <p>In this context, molecular characterization using the Polymerase Chain Reaction (PCR) has emerged as a vital innovation for the rapid and precise identification of pathogens in urinary tract infections. Multiplex real-time PCR allows for the specific detection and amplification of DNA fragments unique to targeted bacteria, offering a more sensitive and specific method compared to traditional urine culture. Urine culture often struggles to differentiate between Klebsiella species (K. pneumoniae and K. oxytoca) and is unable to detect Acinetobacter spp. <xref ref-type="bibr" rid="scirp.136516-15">
     [15]
    </xref>.</p>
   <p>Given the limitations of traditional urine culture, particularly its lengthy turnaround time and difficulty in distinguishing certain uropathogens like Klebsiella spp. and Acinetobacter spp., there is a pressing need for faster, more accurate diagnostic methods. The emergence of molecular techniques, such as multiplex real-time PCR, offers a solution by enabling rapid identification of pathogens and their genetic resistance profiles within the same day. This advancement can significantly reduce unnecessary antibiotic use and improve patient outcomes by offering precise diagnoses in a timely manner. The objectives of this study were: (i) to evaluate, using urine culture, the prevalence rate of urinary tract infections (UTIs) and the resistance rate, and (ii) to identify Klebsiella spp. and Acinetobacter spp. in urine through a molecular approach using multiplex real-time PCR.</p>
  </sec><sec id="s2">
   <title>2. Materials and Methods</title>
   <sec id="s2_1">
    <title>2.1. Type and Period of Study</title>
    <p>This cross-sectional study, with both descriptive and analytical objectives, was conducted from May 3 to July 25, 2023, at the Pietro Annigoni Biomolecular Research Center (CERBA) and the medical biology laboratory of Saint Camille Hospital Ouagadougou (HOSCO).</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Sampling</title>
    <p>A total of 209 urine samples, each ranging from 20 to 30 mL and collected from the first morning void, were obtained from patients prior to any antibiotic intake. After perineal cleansing, midstream urine was collected in a sterile, dry container with a screw lid and promptly transported to the laboratory.</p>
   </sec>
   <sec id="s2_3">
    <title>2.3. Inclusion and Non-Inclusion Criteria</title>
    <p>The examination report should include the following details: the patient’s identity (name, first name, age, sex), the nature of the sample, the clinical assessment, the consultation and/or hospitalization department, and the results of the cytobacteriological examination of the urine (CBEU). Samples collected in non-sterile equipment or suspected of external contamination were excluded from the study.</p>
   </sec>
   <sec id="s2_4">
    <title>2.4. Culture, Identification and Antibiotic Resistance Testing</title>
    <p>The urine cultures were performed using the tight streaking technique with a 10 μL calibrated loop. The culture media used were chromogenic agars from “UriSelect™4 Medium” (Oxoid, United Kingdom), which enabled bacterial identification based on colony coloration, as each bacterium produces a distinctive color. The inoculated media were incubated at 37˚C for 24 hours.</p>
    <p>Antibiotic susceptibility and resistance testing were performed using antibiograms in accordance with the guidelines of the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2023). Fifteen (15) antibiotics were used to assess antimicrobial susceptibility: Amikacin (AMK) (30 μg), Amoxicillin (AML) (25 μg), Amoxicillin/Clavulanic Acid (AMC) (30 μg), Ampicillin/Sulbactam (SAM) (20 μg), Cefepime (FEP) (30 μg), Cefixime (CFM) (5 μg), Cefoxitin (FOX) (30 μg), Ceftazidime (CAZ) (10 μg), Ceftriaxone (CRO) (30 μg), Ciprofloxacin (CIP) (5 μg), Fosfomycin (FOS) (200 μg), Gentamicin (GM) (10 μg), Imipenem (IPM) (10 μg), Levofloxacin (LEV) (5 μg), and Tobramycin (TOB) (10 μg).</p>
   </sec>
   <sec id="s2_5">
    <title>2.5. Molecular Analysis of Urine</title>
    <p>The pathogens tested were bacteria commonly associated with urinary tract infections (UTIs), such as Klebsiella spp. and Acinetobacter spp. For molecular analysis, multiplex real-time PCR was employed to screen for Klebsiella pneumoniae, Klebsiella oxytoca, and Acinetobacter spp. A total of 77 out of 209 samples, including both Klebsiella spp. positive and negative cultures, were analyzed.</p>
    <p>Bacterial genomic DNA was extracted from all strains following the manufacturer’s instructions using the SaMag Bacterial DNA Extraction Kit (Sacace Biotechnologies, Como, Italy). The quantification and purity of the extracted DNA were assessed using a Nanodrop spectrophotometer. A 260/280 nm absorbance ratio between 1.8 and 2.0 was considered indicative of “pure” DNA.</p>
    <p>A reaction volume of 35 µL was prepared according to the manufacturer’s instructions. For each clinical sample and control, one strip of PCR Reaction Mix-1 and one strip of PCR Reaction Mix-2 were used. PCR was performed using the SACACE Biotechnologies thermocycler with the following reaction mixture: 10 μL of Taq polymerase, 5 μL of isolated DNA samples, 5 μL of negative control (in the tube labeled C−, negative extraction control), and 5 μL of positive control (in the tube labeled C+, positive amplification control). All strips were sealed, briefly centrifuged (2 - 3 seconds), and then transferred to the thermocycler, which was pre-programmed with the Bac Multi-Screen Real-TM amplification protocol (<xref ref-type="table" rid="table1">
      Table 1
     </xref>).</p>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.136516-"></xref>Table 1. Amplification program (Sacace biotechnologies, 2022).</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="28.02%"><p style="text-align:center">Steps</p></td> 
       <td class="custom-bottom-td acenter" width="30.10%"><p style="text-align:center">Temperature ˚C</p></td> 
       <td class="custom-bottom-td acenter" width="12.92%"><p style="text-align:center">Min</p></td> 
       <td class="custom-bottom-td acenter" width="19.40%"><p style="text-align:center">Seconds</p></td> 
       <td class="custom-bottom-td acenter" width="23.70%"><p style="text-align:center">Cycles</p></td> 
      </tr> 
      <tr> 
       <td rowspan="2" class="custom-top-td acenter" width="28.02%"><p style="text-align:center">1: denaturation</p></td> 
       <td class="custom-top-td acenter" width="30.10%"><p style="text-align:center">80</p></td> 
       <td class="custom-top-td acenter" width="12.92%"><p style="text-align:center">0</p></td> 
       <td class="custom-top-td acenter" width="19.40%"><p style="text-align:center">30</p></td> 
       <td rowspan="2" class="custom-top-td acenter" width="23.70%"><p style="text-align:center">1</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="30.10%"><p style="text-align:center">94</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="19.40%"><p style="text-align:center">30</p></td> 
      </tr> 
      <tr> 
       <td rowspan="2" class="acenter" width="28.02%"><p style="text-align:center">2: hybridation</p></td> 
       <td class="acenter" width="30.10%"><p style="text-align:center">94</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">0</p></td> 
       <td class="acenter" width="19.40%"><p style="text-align:center">30</p></td> 
       <td rowspan="2" class="acenter" width="23.70%"><p style="text-align:center">5</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="30.10%"><p style="text-align:center">64</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">0</p></td> 
       <td class="acenter" width="19.40%"><p style="text-align:center">15</p></td> 
      </tr> 
      <tr> 
       <td rowspan="2" class="acenter" width="28.02%"><p style="text-align:center">3: extension</p></td> 
       <td class="acenter" width="30.10%"><p style="text-align:center">94</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">0</p></td> 
       <td class="acenter" width="19.40%"><p style="text-align:center">10</p></td> 
       <td rowspan="2" class="acenter" width="23.70%"><p style="text-align:center">45</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="30.10%"><p style="text-align:center">64</p></td> 
       <td class="acenter" width="12.92%"><p style="text-align:center">0</p></td> 
       <td class="acenter" width="19.40%"><p style="text-align:center">15</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>According to the manufacturer’s instructions, the targets were detected by fluorescent signals in the FAM, HEX, ROX, and Cy5 channels. The results were interpreted using the detection program of the Bac Multi-Screen Real-TM amplification protocol and were analyzed directly through the software provided with the real-time PCR instrument (SACACE thermocycler, Como, Italy). The data were presented as amplification curves. Results were validated based on the Ct (threshold cycle) values of each fluorochrome, which were compared to those of the positive controls. A Ct value lower than 26 was considered positive, while a Ct value higher than 26 was considered negative.</p>
   </sec>
   <sec id="s2_6">
    <title>2.6. Data Analysis and Ethical Considerations</title>
    <p>The data was collected using Microsoft Excel 2016 software. Data analysis was per-formed using SPSS version 20.0, EpiInfo 7. Results were considered statistically significant if P &lt; 0.05.</p>
    <p>The Institutional Ethics Committee of HOSCO/CERBA, through Deliberation No. 2023-02-15 dated April 18, 2023, provided a favorable opinion for this study. Confidentiality and anonymity regarding the information obtained from the various patient records were strictly maintained.</p>
   </sec>
  </sec><sec id="s3">
   <title>3. Results</title>
   <sec id="s3_1">
    <title>3.1. Sociodemographic Characteristics</title>
    <p>During this study, 209 cytobacteriological examination of urine (CBEU) samples were collected between May 2023 and July 2024. The samples came from both male and female patients, spanning various age groups. <xref ref-type="table" rid="table2">
      Table 2
     </xref> provides the distribution of patients according to age and sex. Male patients accounted for 52.15% (109/209) of the total, while female patients represented 47.85% (100/209). The age group of 20 to 39 years, across both sexes, was the most represented (35.41%). The average age of all patients was 46.87 ± 21.33 years</p>
   </sec>
   <sec id="s3_2">
    <title>3.2. Results of Clinical Examinations</title>
    <p>Among the patients admitted for urine culture examinations at CERBA or HOSCO, some reported experiencing pain or burning during urination, while others complained of urethral discharge, pelvic pain, dark urine, dysuria, or polyuria.</p>
   </sec>
   <sec id="s3_3">
    <title>3.3. Culture Results</title>
    <p>The frequency of Urinary Tract Infections (UTIs) by gender is presented in <xref ref-type="table" rid="table3">
      Table 3
     </xref>. The results of this study show an overall UTI prevalence rate of 23.44% (49/209). The prevalence rates for males and females were 8.13% and 15.31%, respectively, with a statistically significant difference (P = 0.023).</p>
    <p>The analysis of the pathogens involved, as shown in <xref ref-type="table" rid="table4">
      Table 4
     </xref>, revealed the following prevalence rates: Escherichia coli at 12.92% (27/209), Klebsiella spp. at 7.18% (15/209), Enterobacter cloacae at 1.44% (3/209), Staphylococcus aureus at 0.96% (2/209), Staphylococcus spp. at 0.48% (1/209), and Pseudomonas spp. at 0.48% (1/209).</p>
    <p>
     <xref ref-type="table" rid="table5">
      Table 5
     </xref> presents the resistance rates of the isolated pathogenic microorganisms. Klebsiella spp. exhibited 100% resistance to both Amoxicillin and Amoxicillin/Clavulanic Acid, while Escherichia coli showed 96.2% and 65.4% resistance to Amoxicillin and Amoxicillin/Clavulanic Acid, respectively. However, Klebsiella spp. remained 91.7% susceptible to Imipenem, 80.0% to Gentamicin, and 73.3% to Tobramycin.</p>
   </sec>
   <sec id="s3_4">
    <title>3.4. PCR Results: Prevalence Rates of the Three Germs Tested for by Multiplex Real-Time PCR</title>
    <p>The analysis of the three pathogens involved revealed the following prevalence rates for mono-infections: Klebsiella pneumoniae at 10.39% (8/77), Klebsiella oxytoca at 7.79% (6/77), and Acinetobacter spp. at 7.79% (6/77). Additionally, the prevalence of co-infection with Klebsiella pneumoniae and Acinetobacter spp. was 1.30% (1/209) as shown in <xref ref-type="table" rid="table6">
      Table 6
     </xref>. This molecular study, conducted using multiplex real-time PCR, also demonstrated an overall positivity rate of 23.38% (18/77). The prevalence rates by sex were 12.99% (10/77) for women and 10.39% (8/77) for men, with no statistically significant difference (P = 0.316).</p>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.136516-"></xref>Table 2. Sociodemographic characteristics of the 209 patients.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="22.41%"><p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="15.49%" colspan="2"><p style="text-align:center">Females</p></td> 
       <td class="custom-bottom-td acenter" width="19.22%" colspan="2"><p style="text-align:center">Males</p></td> 
       <td class="custom-bottom-td acenter" width="20.64%" colspan="2"><p style="text-align:center">Total</p></td> 
       <td class="custom-bottom-td acenter" width="27.70%" colspan="2"><p style="text-align:center">Mean age</p></td> 
       <td class="custom-bottom-td acenter" width="9.33%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="22.41%"><p style="text-align:center">Age grouos, years</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="6.82%"><p style="text-align:center">N1</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="8.66%"><p style="text-align:center">%</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="8.45%"><p style="text-align:center">N2</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="10.77%"><p style="text-align:center">%</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="7.38%"><p style="text-align:center">N</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="13.27%"><p style="text-align:center">%</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="12.49%"><p style="text-align:center">Mean</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="15.21%"><p style="text-align:center">Standard deviation</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="9.33%"><p style="text-align:center">P</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="22.41%"><p style="text-align:center">X ˂ 20</p></td> 
       <td class="custom-top-td acenter" width="6.82%"><p style="text-align:center">6</p></td> 
       <td class="custom-top-td acenter" width="8.66%"><p style="text-align:center">2.87</p></td> 
       <td class="custom-top-td acenter" width="8.45%"><p style="text-align:center">11</p></td> 
       <td class="custom-top-td acenter" width="10.77%"><p style="text-align:center">5.26</p></td> 
       <td class="custom-top-td acenter" width="7.38%"><p style="text-align:center">17</p></td> 
       <td class="custom-top-td acenter" width="13.27%"><p style="text-align:center">8.13</p></td> 
       <td class="custom-top-td acenter" width="12.49%"><p style="text-align:center">13.35</p></td> 
       <td class="custom-top-td acenter" width="15.21%"><p style="text-align:center">6.47</p></td> 
       <td class="custom-top-td acenter" width="9.33%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="22.41%"><p style="text-align:center">20 à 39</p></td> 
       <td class="acenter" width="6.82%"><p style="text-align:center">47</p></td> 
       <td class="acenter" width="8.66%"><p style="text-align:center">22.49</p></td> 
       <td class="acenter" width="8.45%"><p style="text-align:center">27</p></td> 
       <td class="acenter" width="10.77%"><p style="text-align:center">12.92</p></td> 
       <td class="acenter" width="7.38%"><p style="text-align:center">74</p></td> 
       <td class="acenter" width="13.27%"><p style="text-align:center">35.41</p></td> 
       <td class="acenter" width="12.49%"><p style="text-align:center">29.32</p></td> 
       <td class="acenter" width="15.21%"><p style="text-align:center">5.06</p></td> 
       <td class="acenter" width="9.33%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="22.41%"><p style="text-align:center">40 à 59</p></td> 
       <td class="acenter" width="6.82%"><p style="text-align:center">24</p></td> 
       <td class="acenter" width="8.66%"><p style="text-align:center">11.48</p></td> 
       <td class="acenter" width="8.45%"><p style="text-align:center">22</p></td> 
       <td class="acenter" width="10.77%"><p style="text-align:center">10.53</p></td> 
       <td class="acenter" width="7.38%"><p style="text-align:center">46</p></td> 
       <td class="acenter" width="13.27%"><p style="text-align:center">22.01</p></td> 
       <td class="acenter" width="12.49%"><p style="text-align:center">49.33</p></td> 
       <td class="acenter" width="15.21%"><p style="text-align:center">6.34</p></td> 
       <td class="acenter" width="9.33%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="22.41%"><p style="text-align:center">60 à 79</p></td> 
       <td class="acenter" width="6.82%"><p style="text-align:center">17</p></td> 
       <td class="acenter" width="8.66%"><p style="text-align:center">8.13</p></td> 
       <td class="acenter" width="8.45%"><p style="text-align:center">41</p></td> 
       <td class="acenter" width="10.77%"><p style="text-align:center">19.62</p></td> 
       <td class="acenter" width="7.38%"><p style="text-align:center">58</p></td> 
       <td class="acenter" width="13.27%"><p style="text-align:center">27.75</p></td> 
       <td class="acenter" width="12.49%"><p style="text-align:center">68.00</p></td> 
       <td class="acenter" width="15.21%"><p style="text-align:center">5.85</p></td> 
       <td class="acenter" width="9.33%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="22.41%"><p style="text-align:center">X ˃ 79</p></td> 
       <td class="acenter" width="6.82%"><p style="text-align:center">6</p></td> 
       <td class="acenter" width="8.66%"><p style="text-align:center">2.87</p></td> 
       <td class="acenter" width="8.45%"><p style="text-align:center">8</p></td> 
       <td class="acenter" width="10.77%"><p style="text-align:center">3.83</p></td> 
       <td class="acenter" width="7.38%"><p style="text-align:center">14</p></td> 
       <td class="acenter" width="13.27%"><p style="text-align:center">6.70</p></td> 
       <td class="acenter" width="12.49%"><p style="text-align:center">85.71</p></td> 
       <td class="acenter" width="15.21%"><p style="text-align:center">4.30</p></td> 
       <td class="acenter" width="9.33%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="22.41%"><p style="text-align:center">Total</p></td> 
       <td class="custom-bottom-td acenter" width="6.82%"><p style="text-align:center">100</p></td> 
       <td class="custom-bottom-td acenter" width="8.66%"><p style="text-align:center">47.85</p></td> 
       <td class="custom-bottom-td acenter" width="8.45%"><p style="text-align:center">109</p></td> 
       <td class="custom-bottom-td acenter" width="10.77%"><p style="text-align:center">52.15</p></td> 
       <td class="custom-bottom-td acenter" width="7.38%"><p style="text-align:center">209</p></td> 
       <td class="custom-bottom-td acenter" width="13.27%"><p style="text-align:center">100.00</p></td> 
       <td class="custom-bottom-td acenter" width="12.49%"><p style="text-align:center">46.87</p></td> 
       <td class="custom-bottom-td acenter" width="15.21%"><p style="text-align:center">21.33</p></td> 
       <td class="custom-bottom-td acenter" width="9.33%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="22.41%"><p style="text-align:center">Sex</p></td> 
       <td class="custom-top-td acenter" width="6.82%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="8.66%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="8.45%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="10.77%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="7.38%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="13.27%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="12.49%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="15.21%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="9.33%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="22.41%"><p style="text-align:center">Females*</p></td> 
       <td class="acenter" width="6.82%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="8.66%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="8.45%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="10.77%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="7.38%"><p style="text-align:center">100</p></td> 
       <td class="acenter" width="13.27%"><p style="text-align:center">47.8</p></td> 
       <td class="acenter" width="12.49%"><p style="text-align:center">42.55</p></td> 
       <td class="acenter" width="15.21%"><p style="text-align:center">19.75</p></td> 
       <td rowspan="2" class="acenter" width="9.33%"><p style="text-align:center"></p><p style="text-align:center">0.005</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="22.41%"><p style="text-align:center">Males°</p></td> 
       <td class="acenter" width="6.82%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="8.66%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="8.45%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="10.77%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="7.38%"><p style="text-align:center">109</p></td> 
       <td class="acenter" width="13.27%"><p style="text-align:center">52.2</p></td> 
       <td class="acenter" width="12.49%"><p style="text-align:center">50.83</p></td> 
       <td class="acenter" width="15.21%"><p style="text-align:center">22.04</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="22.41%"><p style="text-align:center">Total</p></td> 
       <td class="acenter" width="23.94%" colspan="3"><p style="text-align:center">F ---&gt;M: P = 0.002</p></td> 
       <td class="acenter" width="10.77%"><p style="text-align:center"></p></td> 
       <td class="acenter" width="7.38%"><p style="text-align:center">209</p></td> 
       <td class="acenter" width="13.27%"><p style="text-align:center">100.0</p></td> 
       <td class="acenter" width="12.49%"><p style="text-align:center">46.87</p></td> 
       <td class="acenter" width="15.21%"><p style="text-align:center">21.33</p></td> 
       <td class="acenter" width="9.33%"><p style="text-align:center"></p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>
     <xref ref-type="bibr" rid="scirp.136516-"></xref>Table 3. Distribution of the study population by sex based on the positivity of germs isolated by the bacterial culture technique.</p>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td class="custom-bottom-td acenter" width="15.95%"><p style="text-align:center">Sex</p></td> 
      <td class="custom-bottom-td acenter" width="25.62%"><p style="text-align:center">Negative</p></td> 
      <td class="custom-bottom-td acenter" width="22.08%"><p style="text-align:center">Positive</p></td> 
      <td class="custom-bottom-td acenter" width="24.46%"><p style="text-align:center">Total</p></td> 
      <td class="custom-bottom-td acenter" width="11.89%"><p style="text-align:center">P</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="15.95%"><p style="text-align:center">Males</p></td> 
      <td class="custom-top-td acenter" width="25.62%"><p style="text-align:center">92/209 (44.02%)</p></td> 
      <td class="custom-top-td acenter" width="22.08%"><p style="text-align:center">17/209 (8.13%)</p></td> 
      <td class="custom-top-td acenter" width="24.46%"><p style="text-align:center">109/209 (52.15%)</p></td> 
      <td rowspan="2" class="custom-top-td acenter" width="11.89%"><p style="text-align:center"></p><p style="text-align:center">0.023</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="15.95%"><p style="text-align:center">Females</p></td> 
      <td class="acenter" width="25.62%"><p style="text-align:center">68/209 (32.54%)</p></td> 
      <td class="acenter" width="22.08%"><p style="text-align:center">32/209 (15.31%)</p></td> 
      <td class="acenter" width="24.46%"><p style="text-align:center">100/209 (47.85%)</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="15.95%"><p style="text-align:center">Total</p></td> 
      <td class="acenter" width="25.62%"><p style="text-align:center">160/209 (76.56%)</p></td> 
      <td class="acenter" width="22.08%"><p style="text-align:center">49/209 (23.44%)</p></td> 
      <td class="acenter" width="24.46%"><p style="text-align:center">209/209 (100.0%)</p></td> 
      <td class="acenter" width="11.89%"><p style="text-align:center"></p></td> 
     </tr> 
    </table>
    <table-wrap id="table3">
     <label>
      <xref ref-type="table" rid="table3">
       Table 3
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.136516-"></xref>Table 4. Distribution of microorganisms isolated from bacterial culture.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="41.96%"><p style="text-align:center">Isolated uropathogens</p></td> 
       <td class="custom-bottom-td acenter" width="29.16%"><p style="text-align:center">N = 209</p></td> 
       <td class="custom-bottom-td acenter" width="25.86%"><p style="text-align:center">Percentage</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="41.96%"><p style="text-align:center">Mono-infection</p></td> 
       <td class="custom-top-td acenter" width="29.16%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="25.86%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.96%"><p style="text-align:center">Escherichia coli</p></td> 
       <td class="acenter" width="29.16%"><p style="text-align:center">27</p></td> 
       <td class="acenter" width="25.86%"><p style="text-align:center">12.92</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.96%"><p style="text-align:center">Klebsiella spp.</p></td> 
       <td class="acenter" width="29.16%"><p style="text-align:center">15</p></td> 
       <td class="acenter" width="25.86%"><p style="text-align:center">7.18</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.96%"><p style="text-align:center">Enterobacter cloacae</p></td> 
       <td class="acenter" width="29.16%"><p style="text-align:center">3</p></td> 
       <td class="acenter" width="25.86%"><p style="text-align:center">1.44</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.96%"><p style="text-align:center">Staphylococcus aureus</p></td> 
       <td class="acenter" width="29.16%"><p style="text-align:center">2</p></td> 
       <td class="acenter" width="25.86%"><p style="text-align:center">0.96</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.96%"><p style="text-align:center">Staphylococcus sp.</p></td> 
       <td class="acenter" width="29.16%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="25.86%"><p style="text-align:center">0.48</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.96%"><p style="text-align:center">Candida albicans</p></td> 
       <td class="acenter" width="29.16%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="25.86%"><p style="text-align:center">0.48</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.96%"><p style="text-align:center">Pseudomonas sp.</p></td> 
       <td class="acenter" width="29.16%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="25.86%"><p style="text-align:center">0.48</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.96%"><p style="text-align:center">Acinetobacter spp.</p></td> 
       <td class="acenter" width="29.16%"><p style="text-align:center">0</p></td> 
       <td class="acenter" width="25.86%"><p style="text-align:center">0.00</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="41.96%"><p style="text-align:center">Klebsiella oxytoca</p></td> 
       <td class="custom-bottom-td acenter" width="29.16%"><p style="text-align:center">0</p></td> 
       <td class="custom-bottom-td acenter" width="25.86%"><p style="text-align:center">0.00</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="41.96%"><p style="text-align:center">Co-infection</p></td> 
       <td class="custom-top-td acenter" width="29.16%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="25.86%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="41.96%"><p style="text-align:center">E. coli/Klebsiella spp.</p></td> 
       <td class="acenter" width="29.16%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="25.86%"><p style="text-align:center">0.48</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <table-wrap id="table4">
     <label>
      <xref ref-type="table" rid="table4">
       Table 4
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.136516-"></xref>Table 5. Resistance rate of pathogenic microorganisms isolated from bacterial culture.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="17.18%"><p style="text-align:center">Antibiotics</p></td> 
       <td class="custom-bottom-td acenter" width="32.86%" colspan="2"><p style="text-align:center">Escherichia coli (%)</p></td> 
       <td class="custom-bottom-td acenter" width="31.15%" colspan="2"><p style="text-align:center">Klebsiella spp. (%)</p></td> 
       <td class="custom-bottom-td acenter" width="36.33%" colspan="2"><p style="text-align:center">Enterobacter cloacae (%)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="17.18%"><p style="text-align:center"></p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="17.09%"><p style="text-align:center">Resistance</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="15.76%"><p style="text-align:center">Sensibility</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="17.36%"><p style="text-align:center">Resistance</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="13.79%"><p style="text-align:center">Sensibility</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="18.65%"><p style="text-align:center">Resistance</p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="17.68%"><p style="text-align:center">Sensibility</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="17.18%"><p style="text-align:center">AML</p></td> 
       <td class="custom-top-td acenter" width="17.09%"><p style="text-align:center">96.2</p></td> 
       <td class="custom-top-td acenter" width="15.76%"><p style="text-align:center">3.8</p></td> 
       <td class="custom-top-td acenter" width="17.36%"><p style="text-align:center">100.0</p></td> 
       <td class="custom-top-td acenter" width="13.79%"><p style="text-align:center">0.0</p></td> 
       <td class="custom-top-td acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="custom-top-td acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">AMC</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">65.4</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">34.6</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">100.0</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">0.0</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">SAM</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">65.4</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">34.6</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">76.9</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">23.1</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">0.0</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">100.0</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">CIP</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">55.6</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">44.4</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">60.0</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">40.0</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">66.7</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">33.3</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">LEV</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">57.7</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">42.3</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">60.0</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">40.0</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">0.0</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">100.0</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">GM</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">18.5</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">81.5</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">20.0</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">80.0</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">33.3</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">66.7</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">AMK</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">48.1</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">51.9</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">40.0</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">60.0</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">TOB</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">37.0</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">63.0</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">26.7</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">73.3</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">FEP</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">57.7</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">42.3</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">60.0</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">40.0</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">CAZ</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">60.0</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">40.0</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">73.3</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">26.7</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">CRO</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">60.0</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">40.0</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">60.0</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">40.0</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">FOX</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">26.7</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">73.3</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">IPM</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">8.3</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">91.7</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">CFM</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">73.3</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">26.7</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">-</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="17.18%"><p style="text-align:center">FOS</p></td> 
       <td class="acenter" width="17.09%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="15.76%"><p style="text-align:center">-</p></td> 
       <td class="acenter" width="17.36%"><p style="text-align:center">53.3</p></td> 
       <td class="acenter" width="13.79%"><p style="text-align:center">46.7</p></td> 
       <td class="acenter" width="18.65%"><p style="text-align:center">33.3</p></td> 
       <td class="acenter" width="17.68%"><p style="text-align:center">66.7</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>Amikacin (AMK), Amoxicillin (AML), Amoxicillin + Clavulanic Acid (AMC), Ampicillin/sulbactam (SAM), Cefepim (FEP), Cefixime (CFM), Cefoxitin (FOX), Ceftazidime (CAZ), Ceftriaxone (CRO), Ciprofloxacin (CIP), Fosfomycin (FOS), Gentamicin (GM), Imipenem (IPM), Levofloxacin (LEV), Tobramycin (TOB).</p>
    <table-wrap id="table5">
     <label>
      <xref ref-type="table" rid="table5">
       Table 5
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.136516-"></xref>Table 6. Mono- and co-infection rates of bacteria isolated by multiplex real-time PCR and their prevalence by sex.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="37.74%"><p style="text-align:center">Isolated</p></td> 
       <td class="custom-bottom-td acenter" width="20.44%"><p style="text-align:center">Negative</p></td> 
       <td class="custom-bottom-td acenter" width="23.58%"><p style="text-align:center">Positive</p></td> 
       <td class="custom-bottom-td acenter" width="20.44%"><p style="text-align:center">Total</p></td> 
       <td class="custom-bottom-td acenter" width="12.58%"><p style="text-align:center">P</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="37.74%"><p style="text-align:center">Mono-infection</p></td> 
       <td class="custom-top-td acenter" width="20.44%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="23.58%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="20.44%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.74%"><p style="text-align:center">K. pneumoniae</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">69 (89.61%)</p></td> 
       <td class="acenter" width="23.58%"><p style="text-align:center">8 (10.39%)</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">77 (100.00%)</p></td> 
       <td class="acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.74%"><p style="text-align:center">K. oxytoca</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">71 (92.21%)</p></td> 
       <td class="acenter" width="23.58%"><p style="text-align:center">6 (7.79%)</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">77 (100.00%)</p></td> 
       <td class="acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="37.74%"><p style="text-align:center">Acinobacter spp.</p></td> 
       <td class="custom-bottom-td acenter" width="20.44%"><p style="text-align:center">71 (92.21%)</p></td> 
       <td class="custom-bottom-td acenter" width="23.58%"><p style="text-align:center">6 (7.79%)</p></td> 
       <td class="custom-bottom-td acenter" width="20.44%"><p style="text-align:center">77 (100.00%)</p></td> 
       <td class="custom-bottom-td acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="37.74%"><p style="text-align:center">Co-infections</p></td> 
       <td class="custom-top-td acenter" width="20.44%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="23.58%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="20.44%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.74%"><p style="text-align:center">K. pneumoniae/K. oxytoca</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">77 (100.00%)</p></td> 
       <td class="acenter" width="23.58%"><p style="text-align:center">0 (0.00%)</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">77 (100.00%)</p></td> 
       <td class="acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.74%"><p style="text-align:center">K. pneumoniae/Acinobacter spp.</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">76 (98.70%)</p></td> 
       <td class="acenter" width="23.58%"><p style="text-align:center">1 (1.30%)</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">77 (100.00%)</p></td> 
       <td class="acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="37.74%"><p style="text-align:center">K. oxytoca/Acinobacter spp.</p></td> 
       <td class="custom-bottom-td acenter" width="20.44%"><p style="text-align:center">77 (100.00%)</p></td> 
       <td class="custom-bottom-td acenter" width="23.58%"><p style="text-align:center">0 (0.00%)</p></td> 
       <td class="custom-bottom-td acenter" width="20.44%"><p style="text-align:center">77 (100.00%)</p></td> 
       <td class="custom-bottom-td acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="37.74%"><p style="text-align:center">Sex</p></td> 
       <td class="custom-top-td acenter" width="20.44%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="23.58%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="20.44%"><p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.74%"><p style="text-align:center">Females</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">24/77 (31.17%)</p></td> 
       <td class="acenter" width="23.58%"><p style="text-align:center">10/77 (12.99%)</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">34/77 (44.16%)</p></td> 
       <td class="acenter" width="12.58%"><p style="text-align:center">0.616</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.74%"><p style="text-align:center">Males</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">35/77 (45.45%)</p></td> 
       <td class="acenter" width="23.58%"><p style="text-align:center">8/77 (10.39%)</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">43/77 (55.84%)</p></td> 
       <td class="acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.74%"><p style="text-align:center">Total</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">59/77 (76.62%)</p></td> 
       <td class="acenter" width="23.58%"><p style="text-align:center">18/77 (23.38%)</p></td> 
       <td class="acenter" width="20.44%"><p style="text-align:center">77/77 (100.0%)</p></td> 
       <td class="acenter" width="12.58%"><p style="text-align:center"></p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <p>In this study, we evaluated the prevalence of uropathogens, their resistance to antimicrobials, and the potential for diagnosing pathogens that are difficult to identify using conventional bacterial culture, through multiplex real-time PCR.</p>
   <p>Uropathogens Identified by Urine Cultures</p>
   <p>Among the 209 patients who underwent urine culture, 23.44% (49/209) were diagnosed with a urinary tract infection (UTI). This rate is comparable to the findings in Burkina Faso (24.07%) <xref ref-type="bibr" rid="scirp.136516-16">
     [16]
    </xref>, in Bamako (21.9%) <xref ref-type="bibr" rid="scirp.136516-17">
     [17]
    </xref>, in Ghana (22.1%) <xref ref-type="bibr" rid="scirp.136516-18">
     [18]
    </xref>, and in Gabon (29.2 %) <xref ref-type="bibr" rid="scirp.136516-8">
     [8]
    </xref>. However, it is higher than the 18.5% reported in N’Djamena, Chad (18.5%) <xref ref-type="bibr" rid="scirp.136516-19">
     [19]
    </xref>; but lower than the 59.8% found in Cameroun <xref ref-type="bibr" rid="scirp.136516-20">
     [20]
    </xref>. The prevalence of uropathogenic bacteria varies across regions and continents <xref ref-type="bibr" rid="scirp.136516-21">
     [21]
    </xref>, highlighting the need to understand local epidemiology and its changes over time to select effective first-line antibiotic therapies tailored to each area <xref ref-type="bibr" rid="scirp.136516-8">
     [8]
    </xref>.</p>
   <p>In this study, the most prevalent uropathogens, in decreasing order, were: Escherichia coli (12.92%), Klebsiella pneumoniae (4.31%), Enterobacter cloacae (1.44%), and Staphylococcus aureus (0.96%). The prevalence of Escherichia coli in this study is lower than that reported in Ouagadougou (32.76%) <xref ref-type="bibr" rid="scirp.136516-22">
     [22]
    </xref> and (35.5%) <xref ref-type="bibr" rid="scirp.136516-23">
     [23]
    </xref>. Similarly, the prevalence of Klebsiella pneumoniae is lower than that found in Ouagadougou (22%) <xref ref-type="bibr" rid="scirp.136516-23">
     [23]
    </xref> and (10.45%) <xref ref-type="bibr" rid="scirp.136516-22">
     [22]
    </xref> and in Mbarara, in Uganda (12.57%) <xref ref-type="bibr" rid="scirp.136516-24">
     [24]
    </xref>. Variations in prevalence rates could be attributed to differences in study periods, sampling locations, and identification techniques.</p>
   <p>Given that UTIs typically spread through an ascending route and that E. coli is a natural component of the digestive flora, this likely explains its strong predominance in urins samples <xref ref-type="bibr" rid="scirp.136516-25">
     [25]
    </xref>. As several authors have indicated, among the enterobacteria isolated in UTIs, the genus Escherichia is most involved, followed by Klebsiella <xref ref-type="bibr" rid="scirp.136516-26">
     [26]
    </xref>-<xref ref-type="bibr" rid="scirp.136516-28">
     [28]
    </xref>.</p>
   <p>Moreover, this study revealed that UTIs were more prevalent in women (13.40%) compared to men (7.18%), which is consistent with findings from other studies <xref ref-type="bibr" rid="scirp.136516-24">
     [24]
    </xref> <xref ref-type="bibr" rid="scirp.136516-26">
     [26]
    </xref> <xref ref-type="bibr" rid="scirp.136516-29">
     [29]
    </xref>. Factors such as environmental pressure, seasonal variation <xref ref-type="bibr" rid="scirp.136516-24">
     [24]
    </xref>, insufficient hygiene or the anatomical configuration of the female urinary tract could contribute to this difference. However, genetically, women are more resistant to bacterial infections than men due to the “Multiple Copies in T-cell Lymphoma-1” (MCTS1) gene, located at the Xq24 locus on the X chromosome. This gene regulates Interferon gamma (IFN-γ) and the “Janus Kinase 2” (JAK2) gene, which activate immune responses to infections. Since women have two X chromosomes (XX) and men have one (XY), a mutation in the MCTS1 gene on the X chromosome in men could make them more susceptible to infections <xref ref-type="bibr" rid="scirp.136516-30">
     [30]
    </xref>. This genetic difference may explain why certain infectious diseases, such as COVID-19 and AIDS, have higher mortality rates in men than in women <xref ref-type="bibr" rid="scirp.136516-31">
     [31]
    </xref> <xref ref-type="bibr" rid="scirp.136516-32">
     [32]
    </xref>.</p>
   <p>Antibiotic resistance</p>
   <p>In this study, Klebsiella pneumoniae exhibited 100% resistance to Amoxicillin (AML) and Amoxicillin/Clavulanic Acid (AMC), while Escherichia coli showed 96.2% and 65.4% resistance to AML and AMC, respectively. However, Klebsiella pneumoniae remained 87.5% sensitive to Imipenem (IPM) and 77.8% sensitive to Gentamicin (GM). Numerous studies have confirmed the high resistance of uropathogens to antibiotics in Africa <xref ref-type="bibr" rid="scirp.136516-33">
     [33]
    </xref>-<xref ref-type="bibr" rid="scirp.136516-35">
     [35]
    </xref>. Furthermore, Klebsiella spp. resistance to Ceftriaxone (60.0%), Imipenem (26.7%) and Cefoxitin (26.7%) in this study is comparable to that found in Uganda (72.7%), 31.8% and 27.3% respectively <xref ref-type="bibr" rid="scirp.136516-24">
     [24]
    </xref>.</p>
   <p>However, the primary risk factor for antibiotic resistance is repeated prior exposure to the same antibiotic <xref ref-type="bibr" rid="scirp.136516-8">
     [8]
    </xref>. The overuse or misuse of an antibiotic, or a class of antibiotics, fosters the development of bacterial resistance, which can extend to other antibiotic families through the cross-transmission of mobile genetic elements carrying antibiotic resistance genes <xref ref-type="bibr" rid="scirp.136516-36">
     [36]
    </xref> <xref ref-type="bibr" rid="scirp.136516-37">
     [37]
    </xref>. Since UTIs often arise from the ascending contamination of the perineal flora, which reflects the digestive flora, this selection pressure has significant clinical implications <xref ref-type="bibr" rid="scirp.136516-8">
     [8]
    </xref>.</p>
   <p>Although urine culture is currently considered the “gold standard” in bacteriology, it has several limitations. One major drawback is the time required cultures take at least two days to yield results, including sensitivity profiles. This delay in treatment increases the risk of complications, such as upper urinary tract infections (e.g., pyelonephritis), especially when early intervention with empirical antibiotics could have mitigated the symptoms <xref ref-type="bibr" rid="scirp.136516-38">
     [38]
    </xref>. Additionally, certain rare pathogenic species are difficult to identify using conventional bacterial culture techniques. In contrast, molecular diagnostic methods offer a solution to these identification challenges.</p>
   <p>Identification of Uropathogens by Multiplex Real-Time PCR</p>
   <p>Multiplex real-time PCR analysis of three uropathogens yielded an overall positivity prevalence rate of 23.38% (18/77), with prevalence rates of Klebsiella pneumoniae at 10.39% (8/77), Klebsiella oxytoca at 7.79% (6/77), and Acinetobacter spp. at 7.79% (6/77). Among the 18 positive cases, the majority were female, with a prevalence of 12.99%, compared to 10.39% in males (P = 0.462). Additionally, the multiplex real-time PCR identified one co-infection involving Klebsiella pneumoniae and Acinetobacter spp.</p>
   <p>Comparison Between the Diagnosis of Uropathogens by Bacterial Culture and the Multiplex PCR Technique</p>
   <p>According to Sacace Biotechnologies, multiplex real-time PCR offers 100% sensitivity [79.41 - 100] and 100% specificity [98.71 - 100] <xref ref-type="bibr" rid="scirp.136516-39">
     [39]
    </xref>. The results of this study demonstrated the effectiveness and reliability of multiplex real-time PCR by confirming the positivity of all fifteen (15) Klebsiella spp. samples identified by urine culture, including nine (09) samples of Klebsiella pneumoniae and six (06) of Klebsiella oxytoca, which were further identified by PCR.</p>
   <p>Although urine culture is currently considered the gold standard for diagnosing bacterial infections, it faces challenges such as high vulnerability to contamination, with an average contamination rate of 15% in many laboratories <xref ref-type="bibr" rid="scirp.136516-40">
     [40]
    </xref>.</p>
   <p>Contamination, often occurring during the pre-analytical phase of urine culture, can be minimized with proper urine collection, storage, and transport methods <xref ref-type="bibr" rid="scirp.136516-41">
     [41]
    </xref>. False-positive results due to contamination can lead to inappropriate or unnecessary treatments, increasing bacterial resistance, compromising patient outcomes, and escalating healthcare costs <xref ref-type="bibr" rid="scirp.136516-38">
     [38]
    </xref>. Furthermore, the time-consuming nature of culture techniques, often requiring several days for results, has driven the search for faster diagnostic methods like multiplex real-time PCR <xref ref-type="bibr" rid="scirp.136516-42">
     <sup></sup>[42]
    </xref>. Multiplex real-time PCR-based bacterial diagnostics represent a significant advancement in DNA-based laboratory technologies and have become widely available in clinical settings. The use of multiplex PCR, which employs multiple primers to simultaneously detect multiple targets, has reduced both the cost and time of analysis, which explains its growing adoption in clinical medicine <xref ref-type="bibr" rid="scirp.136516-43">
     [43]
    </xref>. According to Xu et al. (2021), PCR not only shows higher detection rates of single pathogens compared to urine culture <xref ref-type="bibr" rid="scirp.136516-44">
     [44]
    </xref> <xref ref-type="bibr" rid="scirp.136516-45">
     [45]
    </xref>, but it is also highly effective at detecting multiple pathogens in urine samples <xref ref-type="bibr" rid="scirp.136516-46">
     [46]
    </xref> such as Klebsiella oxytoca and Acinetobacter spp., which were identified in this study—pathogens that standard urine cultures consistently failed to detect.</p>
  </sec><sec id="s5">
   <title>5. Conclusion</title>
   <p>Bacteriological culture, first pioneered in the 19th century by Louis Pasteur, revolutionized medical diagnostics. However, with ongoing advances in medical technology, newer diagnostic tools with greater sensitivity and specificity—such as multiplex real-time PCR, expanded quantitative urine culture (EQUC), and next-generation sequencing (NGS)—now offer more comprehensive pathogen analyses in significantly less time. This study, for instance, demonstrated that molecular characterization of Klebsiella pneumoniae, Klebsiella oxytoca, and Acinetobacter spp. Using multiplex real-time PCR was completed in less than 24 hours, whereas traditional urine culture required two to three days. The ability to automate urine PCR testing, combined with its accuracy and rapid results, makes multiplex real-time PCR a powerful addition to the diagnostic tools available for managing urinary tract infections in modern medicine.</p>
  </sec><sec id="s6">
   <title>Acknowledgements</title>
   <p>The authors thank Saint Camille Hospital of Ouagadougou (HOSCO) and the Centre de Recherche Biomoléculaire Pietro Annigoni (CERBA) for facilitating data collection.</p>
  </sec><sec id="s7">
   <title>Author Contributions</title>
   <p>JS, HT, TMZ, DO, CN, TS, designed the study.</p>
   <p>JS, TMZ, DO, TS, FWD, AKO, LT, RAO, wrote the manuscript.</p>
   <p>HT, JS, DO, TS, CN, AKO, NB, ATY, PB collected the data.</p>
   <p>JS, HA, AKO, computerized the data.</p>
   <p>HT, DO, TS, AKO, LZ, JS, TMZ, EJTV performed statistical analysis.</p>
   <p>JS, TMZ, DO, TS, DO, FWD, AKO, LT, LZ, RAO, revised and edited the manuscript.</p>
  </sec><sec id="s8">
   <title>Ethical Statement</title>
   <p>The HOSCO/CERBA Institutional Ethics Committee approved this study in Deliberation No. 2023-02-05 of 15 April 18, 2023.The study was conducted according to the declaration of Helsinki.</p>
  </sec><sec id="s9">
   <title>Abbreviations</title>
   <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">AMC</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Amoxicillin + Clavulanic acid</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">AMK</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Amikacin</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">AML</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Amoxicillin</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">AMR</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Antimicrobial resistance</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">CAZ</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Ceftazidime</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">CBEU</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Cytobacteriological examination of urine</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">CERBA</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Pietro Annigoni Biomolecular Research Center</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">CFM</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Cefixime</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">CIP</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Ciprofloxacin</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">CRO</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Ceftriaxone</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">Ct</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Threshold cycle</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">DNA</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Deoxyribonucleic acid</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">FEP</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Cefepim</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">FOS</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Fosfomycin</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">FOX</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Cefoxitin</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">GM</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Gentamicin</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">HOSCO</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Saint Camille Hospital of Ouagadougou</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">IPM</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Imipenem</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">LEV</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Levofloxacin</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">PCR</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Polymerase chain reaction</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">SAM</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Ampicillin/sulbactam</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">SPSS</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Statistical Package for the Social Sciences</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">TOB</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Tobramycin</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="18.60%"><p style="text-align:center">UTI</p></td> 
     <td class="acenter" width="81.40%"><p style="text-align:center">Urinary tract infections</p></td> 
    </tr> 
   </table>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.136516-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kiros, T., et al. (2023) Bacterial Etiology of Urinary Tract Infection and Antibiogram Profile in Children Attending Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia. Interdisciplinary Perspectives on Infectious Diseases, 2023, Article ID: 1035113.
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Xu, Y., Zhu, F., Zhou, Z., Ma, S., Zhang, P., Tan, C., et al. (2024) A Novel mRNA Multi-Epitope Vaccine of Acinetobacter Baumannii Based on Multi-Target Protein Design in Immunoinformatic Approach. BMC Genomics, 25, Article No. 791. &gt;https://doi.org/10.1186/s12864-024-10691-7
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dissinviel, S.K., Nathalie, G., Juste, I.B., Mohamed, B.O., Fernique, K., Abraham, A., et al. (2017) Prevalence and Resistance Profile of Extended-Spectrum-Lactamases-Producing Enterobacteriaceae in Ouagadougou, Burkina Faso. African Journal of Microbiology Research, 11, 1120-1126. &gt;https://doi.org/10.5897/ajmr2017.8598
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Salah, F.D., Soubeiga, S.T., Ouattara, A.K., Sadji, A.Y., Metuor-Dabire, A., Obiri-Yeboah, D., et al. (2019) Distribution of Quinolone Resistance Gene (qnr) in ESBL-Producing Escherichia coli and Klebsiella spp. in Lomé, Togo. Antimicrobial Resistance &amp; Infection Control, 8, Article No. 104. &gt;https://doi.org/10.1186/s13756-019-0552-0
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kpoda, D.S., Guessennd, N., Somda, N.S., Ajayi, A., Bonkoungou, J.I., Konan, F., et al. (2017) Antimicrobial Susceptibility of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae Causing Urinary Tract Infections in Ouagadougou, Burkina Faso. African Journal of Clinical and Experimental Microbiology, 18, 139-144. &gt;https://doi.org/10.4314/ajcem.v18i3.2
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Diagbouga, S., Salah, F.D., et al. (2016) Detection of High Prevalence of TEM/SHV/CTX-M Genes in ESBL Producing and Multidrug Resistant Klebsiella pneumoniae and Klebsiella oxytoca. JBR Journal of Clinical Diagnosis and Research, 4, Article 130. &gt;https://doi.org/10.4172/2376-0311.1000130
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Addis, T., Mekonnen, Y., Ayenew, Z., Fentaw, S. and Biazin, H. (2021) Bacterial Uropathogens and Burden of Antimicrobial Resistance Pattern in Urine Specimens Referred to Ethiopian Public Health Institute. PLOS ONE, 16, e0259602. &gt;https://doi.org/10.1371/journal.pone.0259602
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Mouanga Ndzime, Y., Onanga, R., Kassa Kassa, R.F., Bignoumba, M., Mbehang Nguema, P.P., Gafou, A., et al. (2021) Epidemiology of Community Origin Escherichia coli and Klebsiella pneumoniae Uropathogenic Strains Resistant to Antibiotics in Franceville, Gabon. Infection and Drug Resistance, 14, 585-594. &gt;https://doi.org/10.2147/idr.s296054
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bent, S. (2002) Does This Woman Have an Acute Uncomplicated Urinary Tract Infection? JAMA, 287, 2701-2710. &gt;https://doi.org/10.1001/jama.287.20.2701
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tuon, F.F., Zequinao, T., da Silva, M.S. and Silva, K.O. (2024) eHealth and mHealth in Antimicrobial Stewardship to Reduce Mortality in Empirical Antimicrobial Therapy and a Systematic Review with a Meta-Analysis of Adequate Therapy. Infectious Disease Reports, 16, 707-723. &gt;https://doi.org/10.3390/idr16040054
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bunduki, G.K., Masoamphambe, E., Fox, T., Musaya, J., Musicha, P. and Feasey, N. (2024) Prevalence, Risk Factors, and Antimicrobial Resistance of Endemic Healthcare-Associated Infections in Africa: A Systematic Review and Meta-Analysis. BMC Infectious Diseases, 24, Article No. 158. &gt;https://doi.org/10.1186/s12879-024-09038-0
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Mbuvi, C.M., Musila, B.N. and Nyamache, A.K. (2024) Urogenital Infections among Women Attending Mwingi Hospital, Kitui County, Kenya: Safeguarding Antibiotics Through Microbiological Diagnosis. The East African Health Research Journal, 8, 99-105. 
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Spurbeck, R.R., Dinh, P.C., Walk, S.T., Stapleton, A.E., Hooton, T.M., Nolan, L.K., et al. (2012) Escherichia coli Isolates That Carry vat, fyuA, chuA, and yfcV Efficiently Colonize the Urinary Tract. Infection and Immunity, 80, 4115-4122. &gt;https://doi.org/10.1128/iai.00752-12
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Broeren, M.A.C., Bahçeci, S., Vader, H.L. and Arents, N.L.A. (2011) Screening for Urinary Tract Infection with the Sysmex Uf-1000i Urine Flow Cytometer. Journal of Clinical Microbiology, 49, 1025-1029. &gt;https://doi.org/10.1128/jcm.01669-10
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     van der Kolk, J.H., Endimiani, A., Graubner, C., Gerber, V. and Perreten, V. (2019) Acinetobacter in Veterinary Medicine, with an Emphasis on Acinetobacter Baumannii. Journal of Global Antimicrobial Resistance, 16, 59-71. &gt;https://doi.org/10.1016/j.jgar.2018.08.011
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Sagna, T., Somda, W.D.N., Koné, A., Sagna, Y., Tialla, D., et al. (2019) Antibiotic Susceptibility of Escherichia coli and Klebsiella pneumoniae Strains, Urinary Tract Infections Cases in Bobo-Dioulasso, Burkina Faso. EC Microbiology, 15, 172-178. &gt;https://ecronicon.net/assets/ecmi/pdf/ECMI-15-00605.pdf 
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Soula, G., Pichard, E., Soula, G.G. and Kodio, A. (1990) Étude bactériologique des infections Urinaires à Bamako: Orientation pratique. Médecine d’Afrique Noire, 37, 243-249. &gt;https://www.santetropicale.com/Resume/53703.pdf 
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gambrah, E., Owusu-Ofori, A., Biney, E., Oppong, C. and Coffin, S.E. (2021) Diagnosis and Treatment of Urinary Tract Infections in Hospitalized Adults in Ghana: The Role of the Clinical Microbiology Laboratory in Improving Antimicrobial Stewardship. International Journal of Infectious Diseases, 102, 497-500. &gt;https://doi.org/10.1016/j.ijid.2020.10.068
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Yandai, F.H., Ndoutamia, G., Nadlaou, B. and Barro, N. (2019) Prevalence and Resistance Profile of escherichia Coli and klebsiella Pneumoniae Isolated from Urinary Tract Infections in N’djamena, Tchad. International Journal of Biological and Chemical Sciences, 13, 2065-2073. &gt;https://doi.org/10.4314/ijbcs.v13i4.13
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Nzalie, R.N., Gonsu, H.K. and Koulla-Shiro, S. (2016) Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City. International Journal of Microbiology, 2016, Article ID: 3240268. &gt;https://doi.org/10.1155/2016/3240268
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     El bouamri, M.C., Arsalane, L., Kamouni, Y., Yahyaoui, H., Bennouar, N., Berraha, M., et al. (2014) Profil actuel de résistance aux antibiotiques des souches d’Escherichia coli uropathogènes et conséquences thérapeutiques [Current Antibiotic Resistance Profile of Uropathogenic Escherichia coli Strains and Therapeutic Consequences]. Progrès en Urologie, 24, 1058-1062. &gt;https://doi.org/10.1016/j.purol.2014.09.035
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Karou, S.D., Ilboudo, D.P., Nadembega, W.M.C., Ameyapoh, Y., Ouermi, D., Pignatelli, S., et al. (2009) Antibiotic Resistance in Urinary Tract Bacteria in Ouagadougou. Pakistan Journal of Biological Sciences, 12, 712-716. &gt;https://doi.org/10.3923/pjbs.2009.712.716
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Savadogo, H., Dao, L., Tondé, I., Tamini/Toguyeni, L., Ouédraogo, A.I., Ouermi, A.S., et al. (2021) Infections du tractus urinaire en milieu pédiatrique: Écologie bactérienne et sensibilité aux antibiotiques au Centre hospitalier universitaire pédiatrique Charles-de-Gaulle de Ouagadougou (Burkina Faso). Néphrologie&amp;Thérapeutique, 17, 532-537. &gt;https://doi.org/10.1016/j.nephro.2021.04.003
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Turugurwa, J., Mwesigye, J., Kassaza, K., Byarugaba, F., Kabanda, T. and Musinguzi, B. (2019) Antimicrobial Resistance Patterns and Molecular Characterization of Klebsiella pneumoniae in Clinical Isolates at Mbarara Regional Referral Hospital. Advances in Infectious Diseases, 9, 197-225. &gt;https://doi.org/10.4236/aid.2019.93015
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Niang, A., Ka, R., Sarr, H. and Diop, A. (2020) Phenotypic Characterization of Uropathogenic Bacteria Isolated at Fann CHNU. Dakar Uro’Andro, 2, 56-60.
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref26">
    <label>26</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dia, M., Chabouny, H., Diagne, R., Kâ, R. and Ba-Diallo, A. (2014) Antibiotic Susceptibility Pattern of Uropathogenic Bacterial Isolates in a Dakar Senegalese Teaching. Uro’andro, 2, 71-78.
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref27">
    <label>27</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Adeleye, Q., Ndubuisi, E. and Isa, F. (2024) Etiologic and Anti-Microbial Susceptibility Profiles of Bacterial Urinary Tract Infection and Bacterial Enteritis among Children at a Private Multi-Specialty Healthcare Facility in Abuja, Nigeria: A 5-Year Separate and Comparative Review. Nigerian Journal of Clinical Practice, 27, 35-46. &gt;https://doi.org/10.4103/njcp.njcp_299_23
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref28">
    <label>28</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kebbeh, A., Dsane-Aidoo, P., Sanyang, K., Darboe, S.M.K., Fofana, N., Ameme, D., et al. (2023) Antibiotics Susceptibility Patterns of Uropathogenic Bacteria: A Cross-Sectional Analytic Study at Kanifing General Hospital, the Gambia. BMC Infectious Diseases, 23, Article No. 723. &gt;https://doi.org/10.1186/s12879-023-08373-y
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref29">
    <label>29</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Leotard, S. and Negrin, N. (2010) Épidémiologie des entérobactéries sécrétrices de bêta-lactamases à spectre étendu (E-BLSE) au centre hospitalier de Grasse (2005-2008) [Epidemiology of Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Grasse Hospital (2005-2008)]. Pathologie Biologie, 58, 35-38. &gt;https://doi.org/10.1016/j.patbio.2009.07.014
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref30">
    <label>30</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bohlen, J., Zhou, Q., Philippot, Q., Ogishi, M., Rinchai, D., Nieminen, T., et al. (2023) Human Mcts1-Dependent Translation of JAK2 Is Essential for Ifn-γ Immunity to Mycobacteria. Cell, 186, 5114-5134.e27. &gt;https://doi.org/10.1016/j.cell.2023.09.024
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref31">
    <label>31</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Beegle, K., Demombynes, G., de Walque, D., Gubbins, P. and Veillard, J. (2024) COVID-19 Increased Existing Gender Mortality Gaps in High Income More than Middle Income Countries. International Journal of Infectious Diseases.&gt;https://doi.org/10.1016/j.ijid.2024.107167
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref32">
    <label>32</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ahmadpour, E., Valilou, S., Ghanizadegan, M.A., Seyfi, R., Hosseini, S.A., Hatam-Nahavandi, K., et al. (2024) Global Prevalence, Mortality, and Main Characteristics of Hiv-Associated Pneumocystosis: A Systematic Review and Meta-Analysis. PLOS ONE, 19, e0297619. &gt;https://doi.org/10.1371/journal.pone.0297619
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref33">
    <label>33</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Asamoah, B., Labi, A., Gupte, H.A., Davtyan, H., Peprah, G.M., Adu-Gyan, F., et al. (2022) High Resistance to Antibiotics Recommended in Standard Treatment Guidelines in Ghana: A Cross-Sectional Study of Antimicrobial Resistance Patterns in Patients with Urinary Tract Infections between 2017-2021. International Journal of Environmental Research and Public Health, 19, Article 16556. &gt;https://doi.org/10.3390/ijerph192416556
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref34">
    <label>34</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Adekanmbi, A.O., Akinlabi, O.C., Usidamen, S., Olaposi, A.V. and Olaniyan, A.B. (2022) High Burden of ESBL-Producing Klebsiella Spp., Proteus Mirabilis, Enterobacter Cloacae and Pseudomonas Aeruginosa in Diagnosed Cases of Urinary Tract Infection in a Nigerian Teaching Hospital. Acta Microbiologica et Immunologica Hungarica, 69, 127-134. &gt;https://doi.org/10.1556/030.2022.01747
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref35">
    <label>35</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Campbell, J.S.O., van Henten, S., Koroma, Z., Kamara, I.F., Kamara, G.N., Shewade, H.D., et al. (2022) Culture Requests and Multi-Drug Resistance among Suspected Urinary Tract Infections in Two Tertiary Hospitals in Freetown, Sierra Leone (2017-21): A Cross-Sectional Study. International Journal of Environmental Research and Public Health, 19, Article 4865. &gt;https://doi.org/10.3390/ijerph19084865
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref36">
    <label>36</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Wang, Z., Chen, J., You, Z., Liu, X. and Zhang, J. (2024) [Advances in Mechanisms of Biofilm Formation and Drug Resistance of Staphylococcus aureus]. Chinese Journal of Biotechnology, 40, 2038-2051. 
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref37">
    <label>37</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Brintz, B.J., Madaras-Kelly, K., Nevers, M., Echevarria, K.L., Goetz, M.B. and Samore, M.H. (2024) Predicting Antibiotic Resistance in Enterobacterales to Support Optimal Empiric Treatment of Urinary Tract Infections in Outpatient Veterans. Antimicrobial Stewardship &amp; Healthcare Epidemiology, 4, e118. &gt;https://doi.org/10.1017/ash.2024.377
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref38">
    <label>38</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Xu, R., Deebel, N., Casals, R., Dutta, R. and Mirzazadeh, M. (2021) A New Gold Rush: A Review of Current and Developing Diagnostic Tools for Urinary Tract Infections. Diagnostics, 11, Article 479. &gt;https://doi.org/10.3390/diagnostics11030479
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref39">
    <label>39</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     (2022) Real Time PCR Kit for Detection of DNA of Opportunistic Bacteria of the Classes Bacilli, β-Proteobacteria and γ-Proteobacteria Causing Nosocomial and Community-Acquired Infections. Sacace™ Bac Multi-Screen Real-TM Handbook.
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref40">
    <label>40</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bekeris, L.G., Jones, B.A., Walsh, M.K. and Wagar, E.A. (2008) Urine Culture Contamination: A College of American Pathologists Q-Probes Study of 127 Laboratories. Archives of Pathology &amp; Laboratory Medicine, 132, 913-917. &gt;https://doi.org/10.5858/2008-132-913-uccaco
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref41">
    <label>41</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     LaRocco, M.T., Franek, J., Leibach, E.K., Weissfeld, A.S., Kraft, C.S., Sautter, R.L., et al. (2016) Effectiveness of Preanalytic Practices on Contamination and Diagnostic Accuracy of Urine Cultures: A Laboratory Medicine Best Practices Systematic Review and Meta-Analysis. Clinical Microbiology Reviews, 29, 105-147. &gt;https://doi.org/10.1128/cmr.00030-15
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref42">
    <label>42</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Valentine-King, M.A. and Brown, M.B. (2017) Antibacterial Resistance in Ureaplasma Species and Mycoplasma Hominis Isolates from Urine Cultures in College-Aged Females. Antimicrobial Agents and Chemotherapy, 61, e01104-17. &gt;https://doi.org/10.1128/aac.01104-17
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref43">
    <label>43</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Elnifro, E.M., Ashshi, A.M., Cooper, R.J. and Klapper, P.E. (2000) Multiplex PCR: Optimization and Application in Diagnostic Virology. Clinical Microbiology Reviews, 13, 559-570. &gt;https://doi.org/10.1128/cmr.13.4.559-570.2000
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref44">
    <label>44</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gaydos, C.A., Theodore, M., Dalesio, N., Wood, B.J. and Quinn, T.C. (2004) Comparison of Three Nucleic Acid Amplification Tests for Detection of chlamydia Trachomatis in Urine Specimens. Journal of Clinical Microbiology, 42, 3041-3045. &gt;https://doi.org/10.1128/jcm.42.7.3041-3045.2004
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref45">
    <label>45</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Pillay, A., Radebe, F., Fehler, G., Htun, Y. and Ballard, R.C. (2006) Comparison of a Taqman-Based Real-Time Polymerase Chain Reaction with Conventional Tests for the Detection of Trichomonas Vaginalis. Sexually Transmitted Infections, 83, 126-129. &gt;https://doi.org/10.1136/sti.2006.022376
    </mixed-citation>
   </ref>
   <ref id="scirp.136516-ref46">
    <label>46</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Wojno, K.J., Baunoch, D., Luke, N., Opel, M., Korman, H., Kelly, C., et al. (2020) Multiplex PCR Based Urinary Tract Infection (UTI) Analysis Compared to Traditional Urine Culture in Identifying Significant Pathogens in Symptomatic Patients. Urology, 136, 119-126. &gt;https://doi.org/10.1016/j.urology.2019.10.018
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>